These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17653650)

  • 1. Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation.
    Fabris C; Toniutto P; Bitetto D; Minisini R; Fornasiere E; Smirne C; Pirisi M
    J Gastroenterol; 2007 Jul; 42(7):543-9. PubMed ID: 17653650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight gain after liver transplantation and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene.
    Toniutto P; Fabris C; Minisini R; Apollonio L; Fumo E; Caldato M; Smirne C; Pirisi M
    Transplantation; 2005 May; 79(10):1338-43. PubMed ID: 15912101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ACE gene I/D polymorphism does not affect the susceptibility to or prognosis of PBC.
    Oruç N; Lamb J; Whitcomb DJ; Sass DA
    Turk J Gastroenterol; 2008 Dec; 19(4):250-3. PubMed ID: 19119484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation.
    Toniutto P; Fabris C; Avellini C; Minisini R; Bitetto D; Rossi E; Smirne C; Pirisi M
    World J Gastroenterol; 2005 Oct; 11(38):5944-50. PubMed ID: 16273604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile.
    Fabris C; Toniutto P; Bitetto D; Minisini R; Smirne C; Caldato M; Pirisi M
    Liver Int; 2005 Dec; 25(6):1128-35. PubMed ID: 16343062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of angiotensin converting enzyme insertion/deletion gene polymorphism among an Egyptian cohort of patients with rheumatoid arthritis.
    Ahmed AZ; El-Shahaly HA; Omar AS; Ghattas MH
    Int J Rheum Dis; 2013 Jun; 16(3):284-90. PubMed ID: 23981749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme gene polymorphism (insertion/deletion) and liver fibrosis in Turkish patients from the western Black Sea region, Turkey.
    Turhan NK; Ilikhan SU; Hamamcioglu AC; Ustundag Y; Dursun A; Kokturk F
    Genet Mol Res; 2015 Dec; 14(4):17079-90. PubMed ID: 26681055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation.
    Mas V; Maluf D; Archer KJ; Potter A; Suh J; Gehrau R; Descalzi V; Villamil F
    Liver Transpl; 2011 Jul; 17(7):824-35. PubMed ID: 21618696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
    Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
    Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of angiotensin-converting enzyme polymorphism on progression of hepatic fibrosis in chronic hepatitis C virus infection.
    Raslan HM; Amr KS; Elhosary YA; Ezzat WM; Abdullah NA; El-Batae HE
    Trans R Soc Trop Med Hyg; 2011 Jul; 105(7):396-400. PubMed ID: 21546048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE genotype, body weight changes and target organ damage in renal transplant recipients.
    Stratta P; Smirne C; Fangazio S; Cornella C; Lazzarich E; Minisini R; Toniutto P; Fabris C; Barbé C; Pirisi M
    J Nephrol; 2008; 21(6):879-86. PubMed ID: 19034872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation.
    Guillaud O; Gurram KC; Puglia M; Lilly L; Adeyi O; Renner EL; Selzner N
    Transplant Proc; 2013; 45(6):2331-6. PubMed ID: 23953545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.
    Toniutto P; Fabris C; Falleti E; Cussigh A; Fontanini E; Bitetto D; Fornasiere E; Minisini R; De Feo T; Marangoni F; Pirisi M
    Liver Int; 2008 Feb; 28(2):257-63. PubMed ID: 17900242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional angiotensin converting enzyme gene I/D polymorphism does not alter susceptibility to chronic pancreatitis.
    Oruc N; Lamb J; Kutlu OC; Barmada MM; Money ME; Slivka A; Whitcomb DC
    JOP; 2004 Nov; 5(6):457-63. PubMed ID: 15536282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation.
    Rimola A; Londoño MC; Guevara G; Bruguera M; Navasa M; Forns X; García-Retortillo M; García-Valdecasas JC; Rodes J
    Transplantation; 2004 Sep; 78(5):686-91. PubMed ID: 15371669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.